HB Tempcon Expands Global Biopharma Logistics with New International Route

HB Tempcon Expands Global Biopharma Logistics with New International Route

Haier Biomedical's HB TempCon reefer container has launched international routes, entering the global market and providing secure transportation for biopharmaceutical products, leading the industry's development. This expansion ensures temperature-sensitive biological materials are safely transported across borders, meeting the growing demand for reliable cold chain logistics in the biopharmaceutical sector. The move signifies Haier Biomedical's commitment to innovation and its ambition to become a key player in the global temperature-controlled transportation market.

01/27/2026 Logistics
Read More
Berregene Bios IPO Approval Highlights Biomedical Sector Growth

Berregene Bios IPO Approval Highlights Biomedical Sector Growth

Changzhou Barrygene Biopharmaceutical Co., Ltd. has successfully passed the review of the Beijing Stock Exchange Listing Committee, marking a new stage in the company's development. This article provides an in-depth analysis of the company's core competitiveness, financial data, industry prospects, and listing standards. It also offers investment recommendations, providing valuable reference for investors considering Barrygene. The IPO approval signifies a significant milestone for the company and highlights the growing interest in the biopharmaceutical sector within the Beijing Stock Exchange.

02/03/2026 Logistics Industry Insights
Read More
Ireland Overhauls Biopharma Tariffs to Spur RD and Trade

Ireland Overhauls Biopharma Tariffs to Spur RD and Trade

Ireland has released a biopharmaceutical tariff adjustment plan aimed at reducing R&D and compliance costs, and strengthening its global competitiveness. The new policy focuses on tax reductions for R&D equipment, adaptation to new EU regulations, incentives for high-value drug exports, and restrictions on low-value-added product exports. This move aims to address challenges such as the impact of new EU regulations and increased global competition. It is expected to promote the quality and efficiency of Ireland's biopharmaceutical industry, optimize the global trade landscape, and inject new impetus into Sino-Irish and EU-Irish pharmaceutical trade.

01/15/2026 Customs Knowledge
Read More
UPS Expands Biopharma Cold Chain Services Globally

UPS Expands Biopharma Cold Chain Services Globally

UPS expands its International Special Commodities (ISC) program, adding over 50 international destinations to meet the biopharmaceutical industry's growing demand for cold chain logistics. The program supports the transport of biologics, dangerous goods, and commodities requiring dry ice refrigeration, adhering strictly to international regulations and providing contingency plans for safe and efficient global transportation. This expansion enhances UPS's ability to handle temperature-sensitive shipments, ensuring product integrity and compliance throughout the supply chain for the biomedical sector.

01/29/2026 Logistics
Read More